Mutations in TP53 may result in adrenal cortical carcinoma [49], breast cancer [50], choroid plexus papilloma [51], colorectal cancer [52], hepatocellular carcinoma [53], Li-Fraumeni syndrome [54], nasopharyngeal carcinoma [55], osteosarcoma [56], pancreatic cancer [57], basal cell carcinoma [58], and glioma susceptibility [59]. This evidence concerns the gene TP53 and central nervous system cancer.